IL-17A deficiency in HLA-DR3 transgenic mice enriches beneficial Prevotella species in gut to promote Tregs and reduce CNS autoimmunity

In #Microbiome Gut microbiome combined with anti-IL-17A therapy: A potential new treatment for multiple sclerosis (MS) Read more➡️ doi.org/rdqb #OpenAccess

RRIDs were included in this in Microbiome paper. RRIDs improve reproducibility in scientific research. #OpenScience #OpenResearch #STMpublishing

Can an inflammatory cytokine shape the gut microbiome—and in turn regulate its own immune response? Our new Microbiome paper suggests the answer is yes. 🧵👇 Science often takes longer than expected, but persistence and teamwork, and can bring a story t…